NAMI Advocacy Actions

NAMI works with policymakers to advance priority issues and ensure that the voice of people affected by mental illness is considered in policymaking. Read NAMI’s recent letters to federal leaders, submitted comments and testimony and other resources.

NAMI is committed to ensuring accessibility for people with disabilities. If you would like to request an accessible version of any document on this page, please email us.

Filter By:
Regulatory Comment on Parity
10/16/2023
Regulatory comment to Secretary Yellen, Acting Secretary Su, and Secretary Becerra in support of the proposed rule on Requirements Related to the Mental Health Parity and Addiction Equity Act, and offering comments to strengthen the rule.
Letter to Congressional Committee Leadership on Health Coverage
10/15/2023
Letter providing feedback to the House Budget Committee's Health Care Task Force request for information (RFI) on steps Congress could take to improve outcomes while lowering health care spending.
Letter to Congressional Committee Leadership on Child and Adolescent Mental Health
10/04/2023
Letter in support of H.R.3331/S.754, the Improving Mental Health and Wellness in Schools Act, which would update the current mental health gap in Local School Wellness Policies.
Statement for the Record on Health Coverage
10/03/2023
Statement for the Record affirming the importance of the patient protections afforded by the No Surprises Act and expressing concern about the overwhelming amount of litigation that has hindered the Act's smooth implementation.
Letter to Congressional Leadership on Criminal Justice, Social Supports and Medicaid
09/25/2023
Letter to House leadership urging the swift passage of the Reentry Act (S. 1165/H.R. 2400) and Due Process Continuity of Care Act (S. 971/ H.R. 3074), and expressing disappointment that these bills were excluded from the SUPPORT Act.
Letter to Congressional Committee Leadership on Research and Innovation and Mental Health Funding
09/20/2023
Letter to Appropriations Committee leadership, requesting at least $680 million in FY24 for NIH's Brain Research through Advancing Innovative Neurotechnologies (BRAIN) Initiative.
Letter to Congressional Bill Sponsors on Social Supports
09/12/2023
Letter to Congressional Bill Sponsors in support of the SSI Savings Penalty Elimination Act, which – for the first time in over 30 years – would raise the amount of assets Supplemental Security Income (SSI) recipients can save without jeopardizing their vital SSI benefits.
Regulatory Comment to CMS on Medicare and Medication Access
09/11/2023
Regulatory comment on proposed rule CMS-1784-P, offering suggestions on increasing access to mental health treatments and medications through payment policy in the Medicare Physician Fee Schedule (PFS).
Letter to CMS on Medicare
09/11/2023
Letter to CMS leadership with recommendations for Part D redesign provisions from the Inflation Reduction Act (IRA), with emphasis on ensuring that the Six Protected Classes policy is maintained.
Regulatory Comment on Health Coverage
09/08/2023
Regulatory comment supporting the proposed regulations that would increase transparency and implement consumer safeguards for short-term, limited duration insurance (STLDI) plans.
Displaying results 31-40 (of 325)
 <  1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10  >